Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -32.35% vs 9.84% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -197.83% vs -28.12% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 6.67% vs -71.70% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 15.00% vs -28.57% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Pharming Group NV With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -32.35% vs 9.84% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -17.69% vs 46.87% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -197.83% vs -28.12% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 68.09% vs -22.61% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 6.67% vs -71.70% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 71.43% vs 128.28% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 15.00% vs -28.57% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -52.08% vs 242.86% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






